KRT8P10

Across TCGA pan-cancer cohorts, KRT8P10 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated KRT8P10 data layer.

The strongest signal is observed in pancreatic adenocarcinoma (PAAD), where higher KRT8P10 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated KRT8P10 expression acts as an unfavorable survival marker, although some lineages such as READ and LUSC show a favorable association.

PAAD, OV, and ACC are the cancer types where KRT8P10 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PAAD	OS	Median	All	0.501	0.730	<.001	79	view →
OV	DFS	Quartile	II,III,IV	0.313	0.420	.017	58	view →
ACC	DFS	Tertile	III,IV	0.046	0.670	.001	36	view →
READ	DFS	Tertile	III,IV	0.672	0.309	.007	27	view →
ESCA	OS	Tertile	All	0.436	1.000	.008	24	view →
LUAD	OS	Tertile	All	0.760	0.844	.009	22	view →
MESO	OS	Tertile	IV	0.324	0.813	.006	12	view →
CHOL	OS	Quartile	III,IV	0.138	0.786	.038	6	view →
LUSC	OS	Median	All	0.701	0.609	.021	6	view →
DLBC	OS	Tertile	All	0.219	0.900	.043	6	view →
LIHC	OS	Median	III,IV	0.448	0.690	.013	5	view →
STAD	OS	Median	II,III,IV	0.720	0.626	.022	4	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

KRT8P10–PAAD (OS)

Open the PAAD breakdown →